Roy D Bloom

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint Kidney disease after heart and lung transplantation
    R D Bloom
    Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Am J Transplant 6:671-9. 2006
  2. ncbi request reprint Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list
    Roy D Bloom
    Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Am J Transplant 5:139-44. 2005
  3. doi request reprint Transplant-associated hyperglycemia
    Roy D Bloom
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Transplant Rev (Orlando) 22:39-51. 2008
  4. ncbi request reprint Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients
    R D Bloom
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Transplant 6:2232-7. 2006
  5. doi request reprint Simultaneous liver-kidney transplantation in the MELD era
    Roy D Bloom
    Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA 19104, USA
    Adv Chronic Kidney Dis 16:268-77. 2009
  6. pmc New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies
    Roy D Bloom
    Renal Electrolyte and Hypertension Division, University of Pennsylvania, Founders Building, First Floor, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 3:S38-48. 2008
  7. ncbi request reprint Chronic kidney disease after nonrenal solid-organ transplantation
    Roy D Bloom
    Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Am Soc Nephrol 18:3031-41. 2007
  8. ncbi request reprint Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus
    Roy D Bloom
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Am Soc Nephrol 13:1374-80. 2002
  9. doi request reprint Kidney transplantation in patients with a prior heart transplant
    James R Cassuto
    Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA
    Transplantation 89:427-33. 2010
  10. pmc Assessment of variation in live donor kidney transplantation across transplant centers in the United States
    PETER P REESE
    Renal Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Transplantation 91:1357-63. 2011

Detail Information

Publications60

  1. ncbi request reprint Kidney disease after heart and lung transplantation
    R D Bloom
    Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Am J Transplant 6:671-9. 2006
    ..Based on the impact of chronic kidney disease on outcomes in both heart and lung recipients, we advocate early referral to a nephrologist for patients displaying evidence of significant renal dysfunction...
  2. ncbi request reprint Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list
    Roy D Bloom
    Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Am J Transplant 5:139-44. 2005
    ..Diabetic HCV+ kidney candidates are therefore a patient subgroup that requires frequent and careful reevaluation to ensure ongoing transplantability...
  3. doi request reprint Transplant-associated hyperglycemia
    Roy D Bloom
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Transplant Rev (Orlando) 22:39-51. 2008
    ..Topics of future investigation should include the use of emerging diabetes therapies and avenues for the prevention and reversal of transplant-associated hyperglycemia...
  4. ncbi request reprint Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients
    R D Bloom
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Transplant 6:2232-7. 2006
    ..Data about the potential role of calcineurin inhibitors, corticosteroids and mycophenolate mofetil in HCV infection and HCV-associated NODM will also be discussed...
  5. doi request reprint Simultaneous liver-kidney transplantation in the MELD era
    Roy D Bloom
    Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA 19104, USA
    Adv Chronic Kidney Dis 16:268-77. 2009
    ..This review discusses the issues surrounding simultaneous liver-kidney transplantation and proposes a strategy for selecting patients to receive both organs...
  6. pmc New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies
    Roy D Bloom
    Renal Electrolyte and Hypertension Division, University of Pennsylvania, Founders Building, First Floor, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 3:S38-48. 2008
    ....
  7. ncbi request reprint Chronic kidney disease after nonrenal solid-organ transplantation
    Roy D Bloom
    Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Am Soc Nephrol 18:3031-41. 2007
    ..Finally, future approaches to prevent and treat CKD without compromising function of the transplanted organ are addressed...
  8. ncbi request reprint Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus
    Roy D Bloom
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Am Soc Nephrol 13:1374-80. 2002
    ..0% versus 9.4%; P = 0.521, tacrolimus versus cyclosporine A). In conclusion, HCV is strongly associated with PTDM in renal transplant recipients and appears to account for the increased diabetogenicity observed with tacrolimus...
  9. doi request reprint Kidney transplantation in patients with a prior heart transplant
    James R Cassuto
    Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA
    Transplantation 89:427-33. 2010
    ..The aim of this study was to compare the kidney transplant outcomes among recipients of kidney after prior heart transplantation (KAH, n=456) with kidney transplantation in other clinical settings...
  10. pmc Assessment of variation in live donor kidney transplantation across transplant centers in the United States
    PETER P REESE
    Renal Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Transplantation 91:1357-63. 2011
    ..Transplant centers vary in the proportion of kidney transplants performed using live donors. Clinical innovations that facilitate live donation may drive this variation...
  11. pmc Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection
    PETER P REESE
    University of Pennsylvania, Renal Division, Department of Medicine, Philadelphia, PA, USA
    Clin J Am Soc Nephrol 5:917-23. 2010
    ..This study aimed to identify the proportion of kidney transplant candidates that would accept a kidney from a DIRVI and the factors that influenced this decision...
  12. ncbi request reprint Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes
    Jennifer Trofe-Clark
    Department of Pharmacy Services, Hospital of University of Pennsylvania, Philadelphia, PA 19104 4322, USA
    Transplantation 94:506-12. 2012
    ....
  13. doi request reprint Transplantation: impact of pretransplant renal insufficiency
    Ranjeeta Bahirwani
    Division of Hepatology, University of Pennsylvania Health System, Philadelphia, PA 19010, USA
    Liver Transpl 14:665-71. 2008
    ..In conclusion, few patients with preexisting renal dysfunction, especially if <12 weeks duration, experience a significant drop in eGFR post-OLTa...
  14. ncbi request reprint Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation
    Mical S Campbell
    Division of Gastroenterology, Penn Liver Transplant Center, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Clin Transplant 21:377-84. 2007
    ..The effect of sirolimus on renal function will need to be prospectively evaluated in a prospective, randomized trial...
  15. pmc Age, exclusion criteria, and generalizability of randomized trials enrolling kidney transplant recipients
    Christopher D Blosser
    Department of Medicine, Renal Division, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Transplantation 91:858-63. 2011
    ..It is unknown whether participants in transplant clinical trials-which generate the best evidence for patient care-are representative of the aging population of KTRs...
  16. pmc The influence of induction therapy for kidney transplantation after a non-renal transplant
    James R Cassuto
    Division of Transplantation, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin J Am Soc Nephrol 7:158-66. 2012
    ....
  17. doi request reprint Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation
    PETER P REESE
    Renal Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Liver Int 32:287-96. 2012
    ..Vitamin D deficiency is associated with fractures, infections and death. Liver disease impairs vitamin D and vitamin D binding protein (DBP) metabolism...
  18. ncbi request reprint Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates
    Mical S Campbell
    Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Dig Dis Sci 52:2501-7. 2007
    ..Kidney transplantation alone may be considered in patients with hepatitis C with compensated cirrhosis or bridging fibrosis...
  19. ncbi request reprint Early kidney dysfunction post liver transplantation predicts late chronic kidney disease
    Ergun Velidedeoglu
    Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA
    Transplantation 77:553-6. 2004
    ..Acute and chronic renal dysfunction (ARD, CRD) are common complications after liver transplantation and are associated with poor outcome...
  20. doi request reprint Posttransplant anemia in solid organ recipients
    Christopher D Blosser
    Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Transplant Rev (Orlando) 24:89-98. 2010
    ..Additional treatments may entail removing the cause of the anemia, nutritional supplementation, and/or an erythrocyte stimulating agent...
  21. pmc Short-term outcomes for obese live kidney donors and their recipients
    PETER P REESE
    Renal Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Transplantation 88:662-71. 2009
    ....
  22. pmc Association of metabolic syndrome with development of new-onset diabetes after transplantation
    Nathaniel D Bayer
    Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Transplantation 90:861-6. 2010
    ..Our objective was to determine whether metabolic syndrome pretransplant is independently associated with NODAT development...
  23. ncbi request reprint Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation
    Mical S Campbell
    Division of Gastroenterology, University of Pennsylvania Health System, Philadelphia, PA 19104, USA
    Liver Transpl 11:1048-55. 2005
    ..01) after transplantation. In conclusion, duration, but not cause, of renal dysfunction predicts renal outcome in OLTa recipients. Prospective studies may use duration of renal dysfunction to help identify CKLT candidates...
  24. ncbi request reprint 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course
    Alden M Doyle
    Division of Renal Electrolyte and Hypertension, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Transplantation 81:1106-11. 2006
    ..Optimal CMV prophylaxis is not established. This prospective cohort study compared the safety and efficacy of prophylaxis with 12 versus 24 weeks of oral ganciclovir...
  25. ncbi request reprint Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder
    Donald E Tsai
    Hematologic Malignancies Program, University of Pennsylvania Cancer Center, Philadelphia, PA 19104, USA
    Clin Transplant 19:644-52. 2005
    ..68 wk, p = 0.003). Persistence of MG after complete response of the PTLD did not predict relapse. There is a high incidence of MG and gammaglobulin abnormalities in patients with PTLD...
  26. ncbi request reprint Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil
    K C Mange
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Transplant Proc 34:3119-21. 2002
  27. doi request reprint Maribavir: a novel antiviral agent with activity against cytomegalovirus
    Jennifer Trofe
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Ann Pharmacother 42:1447-57. 2008
    ..To review the pharmacology, pharmacokinetics, efficacy, and safety of maribavir, a novel antiviral agent in the benzimidazole drug class...
  28. doi request reprint Functional status and survival after kidney transplantation
    PETER P REESE
    1 Renal Electrolyte and Hypertension Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 2 Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 3 Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA 4 Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA 5 Department of Biostatistics, University of Pennsylvania, Philadelphia, PA 6 Philadelphia Veteran Affairs Medical Center, Philadelphia, PA 7 Division of Nephrology, University of California San Francisco, San Francisco, CA 8 Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 9 Division of Medical Ethics, New York University, New York, NY 10 Division of Geriatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 11 Address correspondence to Peter P Reese, M D, M S C E, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 917 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104
    Transplantation 97:189-95. 2014
    ..A summary measure of health such as functional status might enable transplant professionals to better evaluate and counsel these patients about their prognosis after transplant...
  29. ncbi request reprint Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantation
    Marty T Sellers
    Department of Surgery Transplantation, University of Pennsylvania, Philadelphia, PA 19104, USA
    Transplantation 78:1670-5. 2004
    ..Now that a uniform definition of "expanded criteria" exists, it is more appropriate than ever to evaluate their utility compared with that seen with non-ECD kidneys...
  30. pmc Recruitment of live donors by candidates for kidney transplantation
    PETER P REESE
    Renal Division, University of Pennsylvania School of Medicine, 1 Founders, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 3:1152-9. 2008
    ..It was hypothesized that preference for live donor kidney transplantation and greater knowledge about live donor transplantation are associated with candidates' initiating conversations about donation with potential donors...
  31. ncbi request reprint Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality
    Anikphe E Imoagene-Oyedeji
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6144, USA
    J Am Soc Nephrol 17:3240-7. 2006
    ..The presence of anemia 3 mo after kidney transplantation is a major determinant of 12-mo PTA. PTA in kidney recipients therefore should be defined by its persistence or occurrence beyond the third posttransplantation month...
  32. doi request reprint Kidney transplantation in patients with HIV infection
    PETER P REESE
    Department of Medicine, Center for Clinical Epidemiology and Biostatistics, and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, USA
    Adv Chronic Kidney Dis 17:94-101. 2010
    ..Long-term follow-up studies will be important to examine these outcomes and the development of malignancy to fully evaluate the risk and benefits of kidney transplantation among HIV-positive recipients...
  33. doi request reprint How should we use age to ration health care? Lessons from the case of kidney transplantation
    PETER P REESE
    Renal Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Am Geriatr Soc 58:1980-6. 2010
    ..This article argues that attempts to use HTA for healthcare rationing are likely to disadvantage older patients. Guiding principles to help ensure that resources such as kidneys are justly allocated across the life span are proposed...
  34. ncbi request reprint Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients
    Ingi Lee
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Transplant 5:2791-5. 2005
    ..These events are often not promptly recognized, and drug discontinuation is delayed. Dapsone-related hemolytic anemia or methemoglobinemia should be considered in solid organ transplant recipients with unexplained anemia or hypoxia...
  35. ncbi request reprint Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients
    Debbie L Cohen
    Renal Division, Hospital of the University of Pennsylvania, 210 White Building, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Am J Hypertens 17:209-12. 2004
    ..The purpose of the study was to determine whether calcineurin inhibitor drugs have any effect on arterial compliance...
  36. ncbi request reprint Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation
    Simin Goral
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 4283, USA
    Nephrol Dial Transplant 23:390-2. 2008
  37. ncbi request reprint Transplant-associated hyperglycemia: a new look at an old problem
    Michael F Crutchlow
    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Clin J Am Soc Nephrol 2:343-55. 2007
    ..Topics of future investigation should include the use of emerging diabetes therapies and avenues for the prevention and reversal of TAH...
  38. doi request reprint Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report
    Miho Murashima
    Department of Medicine, Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Am J Kidney Dis 53:871-4. 2009
    ..124 +/- 0.037 mL/min/kg (0.00207 +/- 0.00062 mL/s/kg). Despite lower clearance by means of peritoneal dialysis compared with hemodialysis, the patient did not develop clinical evidence of methotrexate toxicity...
  39. ncbi request reprint Blood pressure and the survival of renal allografts from living donors
    Kevin C Mange
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine and Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadeplhia, 19104, USA
    J Am Soc Nephrol 15:187-93. 2004
    ..Further investigation is required to confirm the level of BP that is optimal to prevent foreshortened duration of survival...
  40. pmc Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use
    P P Reese
    Department of Medicine, Renal Division, Center for Clniical Epidemiology and Biostatistics and Leonard Davis Institute of Health Economics, University of Pennsylvania, Pennsylvania, PA, USA
    Am J Transplant 9:2338-45. 2009
    ..OPTN should collect detailed data about long-term outcomes and recipient viral testing so the potential risks of CDC kidneys can be fully evaluated...
  41. pmc Predictors of having a potential live donor: a prospective cohort study of kidney transplant candidates
    P P Reese
    Renal Division, 1 Founders Building, University of Pennsylvania, Philadelphia, PA, USA
    Am J Transplant 9:2792-9. 2009
    ..On the other hand, self-efficacy may be an important target in designing interventions to help candidates find live donors...
  42. pmc Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers
    P P Reese
    Department of Medicine, University of Pennsylvania, Renal Division, Philadelphia, PA, USA
    Am J Transplant 8:2062-70. 2008
    ..97, CI 1.23-3.16, p < 0.01) were more likely to use medically complex donors. Though controversial, the use of medically complex donors is widespread and varies widely across centers...
  43. ncbi request reprint A comparison of the survival of shipped and locally transplanted cadaveric renal allografts
    K C Mange
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, USA
    N Engl J Med 345:1237-42. 2001
    ..The effect on allograft survival of the shipment of cadaveric renal allografts from one organ-procurement organization to another is uncertain...
  44. doi request reprint EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial
    D E Tsai
    Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, PA, USA
    Am J Transplant 8:1016-24. 2008
    ..We conclude that EBV PCR is a useful test for managing PTLD patients. While plasma EBNA PCR is the best single assay for diagnosing and monitoring PTLD, the complete PCR panel is superior for ruling out its presence...
  45. pmc Medical follow-up of living kidney donors by 1 year after nephrectomy
    P P Reese
    Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Transplant Proc 41:3545-50. 2009
    ..In 2003, our program developed a policy recommending that donors receive medical follow-up by 12 months postnephrectomy. We hypothesized that medically complex donors would have a higher rate of follow-up than other donors...
  46. ncbi request reprint An overview of solid organ transplantation
    Roy D Bloom
    Renal, Electrolyte, and Hypertension Division, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA
    Clin Chest Med 26:529-43, v. 2005
    ..This article offers an overview of the various solid organ transplant procedures to provide a context within which subsequent articles on pulmonary complications can be viewed...
  47. ncbi request reprint Creating a medical, ethical, and legal framework for complex living kidney donors
    PETER P REESE
    Renal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 1:1148-53. 2006
  48. doi request reprint Viral nephropathies: core curriculum 2008
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Renal, Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Am J Kidney Dis 52:370-81. 2008
  49. pmc Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST)
    Bertram L Kasiske
    Department of Medicine, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, MN 55415, USA
    Am J Kidney Dis 57:908-16. 2011
    ..It is unclear whether benefits outweigh harms for routine screening and prophylactic revascularization to prevent coronary artery disease (CAD) in asymptomatic kidney transplant candidates...
  50. ncbi request reprint Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?
    Kirsten Brukamp
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania School of Medicine, 700 Clinical Research Building, 415 Curie Boulevard, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 1:685-94. 2006
    ..Glomerular lesions after hematopoietic cell transplantation may therefore represent the renal manifestation of GVHD. Further studies are warranted to delineate the pathogenesis of this complication...
  51. ncbi request reprint Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene
    Donald E Tsai
    Hematologic Malignancies Program, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, USA
    Am J Transplant 5:2070-3. 2005
    ..The patient was successfully treated with bexarotene, a novel synthetic retinoid analog, achieving a complete clinical response. Bexarotene may be a promising treatment for T-cell PTLD...
  52. ncbi request reprint Therapeutic drug monitoring of mycophenolic acid
    Leslie M Shaw
    Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 2:1062-72. 2007
  53. ncbi request reprint Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients
    A Israni
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, 19104, USA
    Transplant Proc 36:3019-24. 2004
    ..These results suggest that with the use of 12 weeks of ganciclovir prophylaxis, vigilance for CMV infection is needed well beyond 24 weeks posttransplant...
  54. ncbi request reprint A single-center experience of preemptive anticoagulation for patients with risk factors for allograft thrombosis in renal transplantation
    M Murashima
    Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Clin Nephrol 74:351-7. 2010
    ..to review our single-center experience of preemptive anticoagulation for the prevention of allograft thrombosis in patients with hypercoagulable states...
  55. ncbi request reprint Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient
    Vivek N Ahya
    Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 24:932-5. 2005
    ..We review the literature regarding the safety of inhaled tobramycin and discuss potential mechanisms that may promote systemic toxicity in transplant recipients...
  56. ncbi request reprint Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice
    Roy D Bloom
    Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6144, USA
    Int Immunol 14:867-71. 2002
    ..from those that augment autoantibody production and lymphadenopathy, are necessary for the expression of severe nephritis in MRL-lpr/lpr mice, and they provide further support for a renal antigen-specific component to the phenotype,..
  57. ncbi request reprint Removal of gadolinium by peritoneal dialysis
    M Murashima
    Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Clin Nephrol 69:368-72. 2008
    ....
  58. ncbi request reprint Determinants of coronary artery calcification progression in renal transplant recipients
    K Schankel
    Renal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Am J Transplant 7:2158-64. 2007
    ..Progression is most likely to occur in white patients and is associated with clinical factors such as blood pressure, body mass index, renal function and baseline CAC score...
  59. ncbi request reprint Treatment of PTLD with rituximab or chemotherapy
    R L Elstrom
    Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, USA
    Am J Transplant 6:569-76. 2006
    ..PTLD patients requiring therapy beyond RI should be considered for rituximab, especially with EBV-positive disease. Chemotherapy should be reserved for patients who fail rituximab, have EBV-negative tumors or need a rapid response...
  60. ncbi request reprint Posttransplant lymphoproliferative disorder
    Matthew J Everly
    University of Cincinnati, Cincinnati, OH 45267, USA
    Ann Pharmacother 41:1850-8. 2007
    ..To define and discuss the pathogenesis, clinical presentation, diagnosis, risk factors, and current preventive and treatment strategies of posttransplant lymphoproliferative disorder (PTLD)...